Shoaib M, Stolerman I P
Department of Psychiatry, Institute of Psychiatry, London, UK.
Pharmacol Biochem Behav. 1994 Jul;48(3):749-54. doi: 10.1016/0091-3057(94)90342-5.
Microinjections of nicotine into the fourth ventricle of rats were reported previously to produce a characteristic prostration syndrome; similar microinjections have been investigated for effects on locomotor activity. It was confirmed that nicotine (4 micrograms) administered into the fourth ventricle of rats produced prostration which was also manifested on a second challenge with the drug. Increasing doses of nicotine produced increasing magnitudes of prostration and dose-related decreases in locomotor activity. In rats pretreated with nicotine (0.4 mg/kg SC) for 10 days, no tolerance was seen to either the prostration response or the locomotor depression. Mecamylamine (1.0 mg/kg SC) completely prevented the prostration response produced by 4 micrograms of nicotine, but the locomotor depression was still evident. The locomotor changes following intraventricular administration of nicotine appeared to be different from the locomotor depression seen following systemic administration because the posture of the animals was different and the latter effects showed tolerance with repeated exposures to nicotine and were fully blocked by mecamylamine. These findings suggested that the prostration response and the locomotor depression were mediated by different mechanisms.
先前有报道称,向大鼠第四脑室内微量注射尼古丁会产生一种典型的俯卧综合征;人们已经对类似的微量注射对运动活动的影响进行了研究。已证实,向大鼠第四脑室内注射4微克尼古丁会导致俯卧,再次注射该药物时也会出现这种情况。尼古丁剂量增加会导致俯卧程度增加以及与剂量相关的运动活动减少。在用尼古丁(0.4毫克/千克,皮下注射)预处理10天的大鼠中,未观察到对俯卧反应或运动抑制产生耐受性。美加明(1.0毫克/千克,皮下注射)完全阻止了4微克尼古丁产生的俯卧反应,但运动抑制仍然明显。脑室内注射尼古丁后运动的变化似乎与全身给药后出现的运动抑制不同,因为动物的姿势不同,而且后者的效应在反复接触尼古丁后会产生耐受性,并被美加明完全阻断。这些发现表明,俯卧反应和运动抑制是由不同机制介导的。